Summary
The product Sustanon 250, submitted by Axle Labs, underwent independent testing to verify its authenticity and potency. The manufacturer details were not provided, and the sample was identified by batch number 751 Exp. 10/24. The sample was analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control, and tested for the presence of various testosterone esters and Guaiacol.
The testing process began on 7 August 2024, with the sample received on 12 August 2024, and analysis completed on 13 August 2024. The analysis confirmed a total testosterone ester concentration of 280.37 mg/ml, exceeding the expected 250 mg/ml concentration, while Guaiacol was not detected. This suggests a slightly higher-than-expected dosing of the active ingredients. Independent third-party testing remains essential to ensure consistency and product reliability across different batches. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Axle Labs
- Product Name: Sustanon 250
- Active Ingredients:
- Testosterone Propionate: 35.19 mg/ml
- Testosterone Phenylpropionate: 66.76 mg/ml
- Testosterone Isocaproate: 65.99 mg/ml
- Testosterone Decanoate: 112.43 mg/ml
- Batch Number: 751 Exp. 10/24
- Expiration Date: October 2024
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #47001
- Testing Ordered: 7 August 2024
- Sample Received: 12 August 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Axle Labs
- Analysis Paid For By: Axle Labs
Testing Results
- Specification: 250 mg/ml (as expected)
- Measured Concentration: 280.37 mg/ml
- Guaiacol: Not detected
Verification Details
Verification URL: https://janoshik.com/tests/47001_BR7MFMSCCF5W
Evaluation of Submitted Testing
This analysis confirms the presence of multiple testosterone esters in Sustanon 250, with a total measured concentration of 280.37 mg/ml, which is above the expected label amount. While this suggests potency, the lack of manufacturer details and batch oversight necessitates further scrutiny to ensure consistency across multiple samples. The absence of Guaiacol, a commonly used solvent, may affect product viscosity and injection properties. Janoshik Analytical is recognized for its transparency and rigorous testing protocols; however, further third-party validation is recommended.
Conclusion
The analysis confirms that Sustanon 250 contains multiple testosterone esters totaling 280.37 mg/ml, slightly exceeding the expected concentration, while Guaiacol was not detected. This suggests high potency but highlights the importance of further testing to ensure formulation consistency across batches. This report is provided to support educational and harm reduction efforts, helping consumers make informed choices regarding pharmaceutical products.
Disclaimer
This report is published for educational and harm reduction purposes. Submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
